The Role of Mitogen-activated Protein Kinases in Crystalline Silica-induced Cyclooxygenase-2 Expression in A549 Human Lung Epithelial Cells
Overview
Authors
Affiliations
We examined the role of mitogen-activated protein kinase (MAPK) signaling pathways in crystalline silica-induced expression of cyclooxygenase (COX)-2, an important mediator of airway inflammation, in A549 human lung epithelial cells. The levels of COX-2 mRNA increased after a 30-min exposure, and COX-2 protein increased after a 2-h exposure to crystalline silica. Both remained elevated at 8 h; however, no change was observed in the expression of the constitutive COX-1 isoform. The level of prostaglandin E(2), a major product of COX enzymes, increased in response to crystalline silica exposure. Phosphorylated forms of MAPKs including extracellular signal-regulated protein kinase (ERK), c-Jun NH(2)-terminal kinase, and p38 were also increased after crystalline silica exposure. COX-2 expression was markedly suppressed by treatment with the p38 inhibitor, SB203580, and mildly suppressed by the MAPK/ERK kinase inhibitor, U0126. Treatment with the nuclear factor-κB (NF-κB) inhibitor, BAY11-7082, markedly suppressed silica-induced COX-2 expression. These results show that crystalline silica exposure induces COX-2 expression in A549 cells in a manner that is dependent on the MAPK and NF-κB pathways. Although a marked induction of MAPK phosphatase (MKP)-1 expression was observed in A549 cells exposed to crystalline silica, the silencing of MKP-1 expression using short interference RNA did not affect silica-induced COX-2 expression, suggesting that the down-regulation of COX-2 expression by MKP-1 is unlikely.
McDonald O, Wagner J, Lewandowski R, Heine L, Estrada V, Pourmand E Inhal Toxicol. 2024; 36(7-8):442-460.
PMID: 39418113 PMC: 11606782. DOI: 10.1080/08958378.2024.2413373.
Extracellular signal-regulated kinase signaling pathway and silicosis.
Xie Y, Ma J, Yang M, Fan L, Chen W Toxicol Res (Camb). 2021; 10(3):487-494.
PMID: 34141162 PMC: 8201546. DOI: 10.1093/toxres/tfaa109.
Foster M, Ord J, Zhao E, Birukova A, Fee L, Korte F Front Immunol. 2019; 10:2336.
PMID: 31632407 PMC: 6781616. DOI: 10.3389/fimmu.2019.02336.
Hegde B, Bodduluri S, Satpathy S, Alghsham R, Jala V, Uriarte S J Immunol. 2018; 200(10):3556-3567.
PMID: 29610142 PMC: 5940517. DOI: 10.4049/jimmunol.1701504.
Farris B, Antonini J, Fedan J, Mercer R, Roach K, Chen B Inhal Toxicol. 2017; 29(7):322-339.
PMID: 28967277 PMC: 6545482. DOI: 10.1080/08958378.2017.1361487.